Ritholtz Wealth Management Puma Biotechnology, Inc. Transaction History
Ritholtz Wealth Management
- $3 Billion
- Q2 2024
A detailed history of Ritholtz Wealth Management transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Ritholtz Wealth Management holds 33,759 shares of PBYI stock, worth $85,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,759
Previous 37,324
9.55%
Holding current value
$85,072
Previous $197,000
44.16%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PBYI
# of Institutions
99Shares Held
30.5MCall Options Held
73.5KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA3.6MShares$9.07 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.16MShares$7.97 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.06MShares$7.72 Million0.59% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$4.92 Million0.02% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $115M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...